Product Information
LITHIUM CARBONATE ER 300 MG TB is a generic product labeled by American Health Packaging, priced at $0.2012 per EA under NDC 68084064001. Its NADAC has been published 601 times since Dec 24, 2014.
Strength
300 mg/1
Manufacturer
American Health PackagingNDC
68084064001
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA076832On Market Since
10/13/2014
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE ER 300 MG TB has been published 601 times since Dec 24, 2014, and over the history we have for it it has risen 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2012 per EA |
|---|---|
| All-time high | $0.2271 (Nov 13, 2024) |
| All-time low | $0.1260 (Dec 21, 2022) |
| 52-week high | $0.2172 |
| 52-week low | $0.1991 |
| Median price | $0.1571 |
| Average price | $0.1665 |
| Largest weekly change | +33.8% (Jun 19, 2024) |
| Weeks tracked | 601 |
| Tracking since | Dec 24, 2014 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE ER 300 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE ER 300 MG TB, manufactured by American Health Packaging, is $0.2012 per EA (NDC 68084064001), effective Jun 24, 2026.
How has the price of LITHIUM CARBONATE ER 300 MG TB changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE ER 300 MG TB has risen 6.1%. It has been tracked across 601 weekly CMS publications since Dec 24, 2014.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE ER 300 MG TB?
Since Dec 24, 2014, the NADAC for LITHIUM CARBONATE ER 300 MG TB has ranged from a low of $0.1260 (Dec 21, 2022) to a high of $0.2271 (Nov 13, 2024), with a median of $0.1571 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE ER 300 MG TB?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LITHIUM CARBONATE 300 MG CAP, is $0.0959 per EA — about 52% below LITHIUM CARBONATE ER 300 MG TB.
Who manufactures LITHIUM CARBONATE ER 300 MG TB?
LITHIUM CARBONATE ER 300 MG TB (NDC 68084064001) is labeled by American Health Packaging, and CMS classifies it as a generic product.
Related Drugs
Same classification